![]() ![]() Because these statements reflect Endo's current views, expectations and beliefs concerning future events, these forward-looking statements involve risks and uncertainties. Statements including words such as "believes," "expects," "anticipates," "intends," "estimates," "plan," "will," "may," "look forward," "intend," "guidance," "future" or similar expressions are forward-looking statements. Ĭautionary Note Regarding Forward-Looking StatementsĬertain information in this press release contains certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and applicable Canadian securities legislation. Par is an operating company of Endo International plc. Par is advancing a robust research and development (R&D) pipeline of potential products. generics industry, possesses a portfolio that includes sterile injectables, alternative dosage forms and many other differentiated products. Par Pharmaceutical, headquartered in Chestnut Ridge, NY, develops, manufactures and markets safe, innovative and cost-effective generic pharmaceutical and branded injectable products that help improve patient quality of life. Endo has global headquarters in Dublin, Ireland, and U.S. PROVENTIL ® is a registered trademark of Merck Sharp & Dohme Corp.Įndo International plc (NASDAQ: ENDP) is a highly focused generics and specialty branded pharmaceutical company delivering quality medicines to patients in need through excellence in development, manufacturing and commercialization. "Par has partnered with Merck several times to bring an authorized generic product to market and we are proud to be a reliable, quality supplier." "We are very pleased to add albuterol sulfate to Par's portfolio and to be able to offer the authorized generic of the product to patients," said Tony Pera, President of Par Pharmaceutical. allowing Par to launch and distribute an authorized generic of the product. supply and distribution agreement with a subsidiary of Merck & Co., Inc., of Kenilworth, N.J. Endo's subsidiary, Endo Procurement Operations Limited, recently entered into an exclusive U.S. The data presented on this page does not represent the view of Endo Pharmaceuticals Inc and its employees or that of Zippia.Įndo Pharmaceuticals Inc may also be known as or be related to ENDO HEALTH SOLUTIONS INC., Endo Health Solutions Inc, Endo Health Solutions Inc., Endo International plc, Endo Pharmaceuticals and Endo Pharmaceuticals Inc.DUBLIN, Ap/PRNewswire/ - Endo International plc (NASDAQ: ENDP) announced today that one of its operating companies, Par Pharmaceutical (Par), has begun shipping an authorized generic version of Merck's PROVENTIL ® (albuterol sulfate) HFA Inhalation Aerosol, 120mcg. None of the information on this page has been provided or approved by Endo Pharmaceuticals Inc. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. The employee data is based on information from people who have self-reported their past or current employments at Endo Pharmaceuticals Inc. ![]() Zippia gives an in-depth look into the details of Endo Pharmaceuticals Inc, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Endo Pharmaceuticals Inc. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |